Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06188221 · ClinicalTrials.gov registry record · NA
Does Adding Lidocaine to Corticosteroid Injections Reduce Pain Intensity in Hand Surgery
A NA study of Carpal Tunnel Syndrome and Trigger Finger, sponsored by University of Texas at Austin.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT06188221: Completed NA study of Carpal Tunnel Syndrome and Trigger Finger, sponsored by University of Texas at Austin.
NCT06188221 is a NA study of Carpal Tunnel Syndrome and Trigger Finger that has completed, run by University of Texas at Austin. The registered enrollment target is 40 participants, below the 221-participant average among 21 other Carpal Tunnel Syndrome trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06188221, a NA study of Carpal Tunnel Syndrome and Trigger Finger, has completed, sponsored by University of Texas at Austin.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study was to determine whether adding Lidocaine to Corticosteroid injections reduce pain intensity in hand surgery.
Primary Outcome
11-point ordinal scale, with 0 for no pain at all and 10 for worst pain ever
Conditions Studied
Interventions
- DRUG Lidocaine
- DRUG Corticoids
Study Locations (1)
Texas
- University of Texas Health Austin (UTHA) - Austin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2020-02-01 |
| Est. Completion | 2023-07-01 |
| Phase | NA |
What the finished NCT06188221 record still lists
NCT06188221 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 221-participant average among 21 other Carpal Tunnel Syndrome trials with a reported enrollment target (82% lower).
The record links to 3 conditions, with Carpal Tunnel Syndrome appearing as the primary indexed condition, and to 2 interventions - of which Lidocaine is the first listed.
NCT06188221 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06188221 about?
NCT06188221 is a clinical study titled "Does Adding Lidocaine to Corticosteroid Injections Reduce Pain Intensity in Hand Surgery". The purpose of this study was to determine whether adding Lidocaine to Corticosteroid injections reduce pain intensity in hand surgery.
What is the current status of trial NCT06188221?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2020-02-01. Estimated completion is 2023-07-01.
What conditions does trial NCT06188221 study?
This clinical trial studies the following conditions: Carpal Tunnel Syndrome, Trigger Finger, Hand Osteoarthritis.
What interventions are being tested in trial NCT06188221?
The interventions under investigation include: Lidocaine (DRUG), Corticoids (DRUG).
Who is sponsoring clinical trial NCT06188221?
This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06188221 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Carpal Tunnel Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06188221's enrollment target sits among peer trials
40 20th of 21 higher than 1 of 21 other Carpal Tunnel Syndrome trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Carpal Tunnel Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Carpal Arch Space Augmentation (CASA) Clinical Trial
RECRUITING · NA
-
Effect of Cooling Therapy for Post-Operative Pain in Open Carpal Tunnel Release
RECRUITING · NA
-
Small Nerve Fiber Activity in Patients with Carpal Tunnel Syndrome Assessed Via Quantitative Sensory Testing
RECRUITING · NA
-
Noninvasive Brain Stimulation for Treating Carpal Tunnel Syndrome
RECRUITING · NA
-
Efficacy of Red Kinesiology Tape on Carpal Tunnel-Like Symptoms and Performance in Esports Gamers
RECRUITING · NA
-
Postoperative Care After Carpal Tunnel Release Using Short Educational Videos
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI